Negative serology of Fasciola hepatica infection in patients with liver cancer in Peru: a preliminary report - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Revista da Sociedade Brasileira de Medicina Tropical Année : 2018

Negative serology of Fasciola hepatica infection in patients with liver cancer in Peru: a preliminary report

Résumé

Introduction: The etiology of several hepatocellular carcinoma (HCC) cases remains largely unknown. Although Fasciola hepatica has been associated with liver fibrosis in Latin America, it has not yet been associated with HCC. This study aimed to determine the existence of specific IgG antibodies against F. hepatica in the serum samples of HCC patients. Methods: In total, 13 serum samples from 13 HCC patients were screened using Fas2-ELISA. Results: Fas2-ELISA demonstrated negative results in all HCC patients included in this study. Conclusions: The pre-existence of F. hepatica infection in HCC patients needs to be further investigated in epidemiological and experimental studies.
Fichier principal
Vignette du fichier
1678-9849-rsbmt-51-02-231.pdf (824.08 Ko) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte
Loading...

Dates et versions

hal-01793677 , version 1 (16-05-2018)

Identifiants

Citer

Claudia Machicado, Stephane Bertani, Patricia Herrera-Velit, Jose Espinoza, Eloy Ruiz, et al.. Negative serology of Fasciola hepatica infection in patients with liver cancer in Peru: a preliminary report. Revista da Sociedade Brasileira de Medicina Tropical, 2018, 51 (2), pp.231 - 233. ⟨10.1590/0037-8682-0180-2017⟩. ⟨hal-01793677⟩
45 Consultations
60 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More